Cargando…
Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
BACKGROUND: Recent studies have highlighted that uncoupling of sarco-/endoplasmic reticulum Ca(2+)-ATPase (SERCA) by sarcolipin (SLN) increases ATP consumption and contributes to heat liberation. Exploiting this thermogenic mechanism in skeletal muscle may provide an attractive strategy to counterac...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270280/ https://www.ncbi.nlm.nih.gov/pubmed/35364719 http://dx.doi.org/10.1007/s11033-022-07387-0 |
_version_ | 1784744427841912832 |
---|---|
author | Mengeste, Abel M. Katare, Parmeshwar Dalmao Fernandez, Andrea Lund, Jenny Bakke, Hege G. Baker, David Bartesaghi, Stefano Peng, Xiao-Rong Rustan, Arild C. Thoresen, G. Hege Kase, Eili Tranheim |
author_facet | Mengeste, Abel M. Katare, Parmeshwar Dalmao Fernandez, Andrea Lund, Jenny Bakke, Hege G. Baker, David Bartesaghi, Stefano Peng, Xiao-Rong Rustan, Arild C. Thoresen, G. Hege Kase, Eili Tranheim |
author_sort | Mengeste, Abel M. |
collection | PubMed |
description | BACKGROUND: Recent studies have highlighted that uncoupling of sarco-/endoplasmic reticulum Ca(2+)-ATPase (SERCA) by sarcolipin (SLN) increases ATP consumption and contributes to heat liberation. Exploiting this thermogenic mechanism in skeletal muscle may provide an attractive strategy to counteract obesity and associated metabolic disorders. In the present study, we have investigated the role of SLN on substrate metabolism in human skeletal muscle cells. METHODS AND RESULTS: After generation of skeletal muscle cells with stable SLN knockdown (SLN-KD), cell viability, glucose and oleic acid (OA) metabolism, mitochondrial function, as well as gene expressions were determined. Depletion of SLN did not influence cell viability. However, glucose and OA oxidation were diminished in SLN-KD cells compared to control myotubes. Basal respiration measured by respirometry was also observed to be reduced in cells with SLN-KD. The metabolic perturbation in SLN-KD cells was reflected by reduced gene expression levels of peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α) and forkhead box O1 (FOXO1). Furthermore, accumulation of OA was increased in cells with SLN-KD compared to control cells. These effects were accompanied by increased lipid formation and incorporation of OA into complex lipids. Additionally, formation of complex lipids and free fatty acid from de novo lipogenesis with acetate as substrate was enhanced in SLN-KD cells. Detection of lipid droplets using Oil red O staining also showed increased lipid accumulation in SLN-KD cells. CONCLUSIONS: Overall, our study sheds light on the importance of SLN in maintaining metabolic homeostasis in human skeletal muscle. Findings from the current study suggest that therapeutic strategies involving SLN-mediated futile cycling of SERCA might have significant implications in the treatment of obesity and associated metabolic disorders. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9270280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-92702802022-07-10 Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells Mengeste, Abel M. Katare, Parmeshwar Dalmao Fernandez, Andrea Lund, Jenny Bakke, Hege G. Baker, David Bartesaghi, Stefano Peng, Xiao-Rong Rustan, Arild C. Thoresen, G. Hege Kase, Eili Tranheim Mol Biol Rep Original Article BACKGROUND: Recent studies have highlighted that uncoupling of sarco-/endoplasmic reticulum Ca(2+)-ATPase (SERCA) by sarcolipin (SLN) increases ATP consumption and contributes to heat liberation. Exploiting this thermogenic mechanism in skeletal muscle may provide an attractive strategy to counteract obesity and associated metabolic disorders. In the present study, we have investigated the role of SLN on substrate metabolism in human skeletal muscle cells. METHODS AND RESULTS: After generation of skeletal muscle cells with stable SLN knockdown (SLN-KD), cell viability, glucose and oleic acid (OA) metabolism, mitochondrial function, as well as gene expressions were determined. Depletion of SLN did not influence cell viability. However, glucose and OA oxidation were diminished in SLN-KD cells compared to control myotubes. Basal respiration measured by respirometry was also observed to be reduced in cells with SLN-KD. The metabolic perturbation in SLN-KD cells was reflected by reduced gene expression levels of peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α) and forkhead box O1 (FOXO1). Furthermore, accumulation of OA was increased in cells with SLN-KD compared to control cells. These effects were accompanied by increased lipid formation and incorporation of OA into complex lipids. Additionally, formation of complex lipids and free fatty acid from de novo lipogenesis with acetate as substrate was enhanced in SLN-KD cells. Detection of lipid droplets using Oil red O staining also showed increased lipid accumulation in SLN-KD cells. CONCLUSIONS: Overall, our study sheds light on the importance of SLN in maintaining metabolic homeostasis in human skeletal muscle. Findings from the current study suggest that therapeutic strategies involving SLN-mediated futile cycling of SERCA might have significant implications in the treatment of obesity and associated metabolic disorders. GRAPHICAL ABSTRACT: [Image: see text] Springer Netherlands 2022-04-02 2022 /pmc/articles/PMC9270280/ /pubmed/35364719 http://dx.doi.org/10.1007/s11033-022-07387-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Mengeste, Abel M. Katare, Parmeshwar Dalmao Fernandez, Andrea Lund, Jenny Bakke, Hege G. Baker, David Bartesaghi, Stefano Peng, Xiao-Rong Rustan, Arild C. Thoresen, G. Hege Kase, Eili Tranheim Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells |
title | Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells |
title_full | Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells |
title_fullStr | Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells |
title_full_unstemmed | Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells |
title_short | Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells |
title_sort | knockdown of sarcolipin (sln) impairs substrate utilization in human skeletal muscle cells |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270280/ https://www.ncbi.nlm.nih.gov/pubmed/35364719 http://dx.doi.org/10.1007/s11033-022-07387-0 |
work_keys_str_mv | AT mengesteabelm knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT katareparmeshwar knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT dalmaofernandezandrea knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT lundjenny knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT bakkehegeg knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT bakerdavid knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT bartesaghistefano knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT pengxiaorong knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT rustanarildc knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT thoresenghege knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells AT kaseeilitranheim knockdownofsarcolipinslnimpairssubstrateutilizationinhumanskeletalmusclecells |